% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • piper_jefferies_1 piper_jefferies_1 Nov 8, 2013 11:28 AM Flag

    Should not be trading under $90

    beat earnings and raised guidance. at this prescription rate they will most likely beat earnings next quarter as well. they are also going to acquire additional assets

    market potential based on company presentation:
    3k patients US
    3k patients EU
    10k rest of world
    1yr prescription = $295k

    ~$4.7B market w/ no current competitors for microsomal triglyceride transfer protein inhibitor compounds for the treatment of hyperlipidemia

1.54-0.13(-7.78%)Jun 24 4:00 PMEDT